Eukaryotes are thought to have originated through a process known as endosymbiosis, in which an ancestral prokaryotic cell engulfed another, forming a mutually beneficial relationship. Over time, the ...

In a groundbreaking study on the synthesis of cellulose -- a major constituent of all plant cell walls -- a team has captured images of the microscopic process of cell-wall building continuously ...

Cell polarity is the asymmetric organisation of several cellular components, including its plasma membrane, cytoskeleton or organelles. This asymmetry can be used for specialised functions, such ...

GPR35 controls the transmembrane ion gradient by regulating Na/K-ATPase function with knock-on effects on osmosis, cellular stress and glutamine uptake. LYCHOS, a lysosomal membrane protein ...

Those cancers begin in other types of tissue, such as: Basal cell carcinoma. This is the most common form of all cancers. It occurs in cells lining the deepest part of the skin's outer layer.

(Brief account only) Cell theory and cell as the basic unit of life; Structure of prokaryotic and eukaryotic cell; Plant cell and animal cell; Cell envelope, cell membrane, cell wall; Cell organelles ...

Structure of prokaryotic and eukaryotic cell; Plant cell and animal cell; Cell envelope, cell membrane, cell wall; Cell organelles structure and function; Endomembrane system-endoplasmic reticulum ...

Mar. 27, 2025 — Scientists have uncovered a surprising role for calcium in shaping the building blocks of life. Their study reveals that calcium ions help determine the molecular 'handedness ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer that forms in your white blood cells called lymphocytes. These cells are made by your lymphatic system, which plays an important role in immunity.

"It's much like doing a medical CT scan where you can see inside of the cell non-destructively, so you don't have to cut the cell open," says Carolyn Larabell, a cell biologist at UC San Francisco.

AstraZeneca bought Belgian biotech company EsoBiotec in a deal valued at up to $1 billion, to expand its cell-therapy portfolio. The British pharma company said Monday that it will pay $425 ...